Skip to content

Clinical trials

Obesity trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Japan Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20073
20092
20122
20172
20183
20193
20215
20224
202313
202413
202518
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting24
Active, not recruiting17
Not yet recruiting6
Terminated4
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company28
Novo Nordisk A/S21
Amgen10
AstraZeneca10
Boehringer Ingelheim5
Pfizer5
Sanofi4
Hiroshima University3
Hoffmann-La Roche2
Bispebjerg Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity96
Overweight55
Diabetes Mellitus, Type 224
Nutrition Disorders7
Diabetes Mellitus5
Hypertension5
Sleep Apnea, Obstructive5
Weight Loss4
Atherosclerosis3
Metabolic Syndrome3

Trials

Showing 51 to 75 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.